Public company research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Open in CopyWindow

Company research history

TuHURA Biosciences, Inc. - Common Stock (HURA)

Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.

2 disclosures
1 insider
0 cluster signals
0.0% avg. 30d outcome

Company facts

Ticker / ISIN
HURA / Not available
Exchange
Not available
Country
US
Sector
Not available

Disclosure history

Laurel Lee, Representative

buy disclosed on 9 Aug 2025 via House STOCK Act disclosures

Transaction value
US$50,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Laurel Lee, Representative

buy disclosed on 7 Jan 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%